首页> 外文期刊>The Journal of Nuclear Medicine >In Vivo Characterization of 4 Ga-68-Labeled Multimeric RGD Peptides to Image alpha(v)beta(3) Integrin Expression in 2 Human Tumor Xenograft Mouse Models
【24h】

In Vivo Characterization of 4 Ga-68-Labeled Multimeric RGD Peptides to Image alpha(v)beta(3) Integrin Expression in 2 Human Tumor Xenograft Mouse Models

机译:在2个人肿瘤异种移植小鼠模型中,在4A-68标记的多聚体RGD肽的体内表征4AG-68标记的多聚体RGD肽(V)β(3)整合蛋白表达

获取原文
获取原文并翻译 | 示例
           

摘要

alpha(v)beta(3) integrins play an important role in angiogenesis and cell migration in cancer and are highly expressed on the activated endothelial cells of newly formed blood vessels. Here, we compare the targeting characteristics of 4 Ga-68-labeled multimeric cyclic arginine-glycine-aspartate (RGD)-based tracers in an alpha(v)beta(3) integrin-expressing tumor model and a tumor model in which alpha(v)beta(3) integrin is expressed solely on the neovasculature. Methods: Female BALB/c nude mice were subcutaneously injected with SK-RC-52 (alpha(v)beta(3) integrin-positive) or FaDu (alpha(v)beta(3) integrin-negative) tumor cells. 68Ga-labeled DOTA-(RGD)(2), TRAP-(RGD)(3), FSC-(RGD)(3), or THP-(RGD)(3) was intravenously administered to the mice (0.5 nmol per mouse, 10-20 MBq), followed by small-animal PET/CT imaging and ex vivo biodistribution studies 1 h after injection. Nonspecific uptake of the tracers in both models was determined by coinjecting an excess of unlabeled DOTA-(RGD) 2 (50 nmol) along with the radiolabeled tracers. Results: Imaging and biodistribution data showed specific uptake in the tumors for each tracer in both models. Tumor uptake of Ga-68-FSC-(RGD)(3) was significantly higher than that of Ga-68-DOTA-(RGD)(2), Ga-68-TRAP-(RGD)(3), or Ga-68-THP-(RGD)(3) in the SK-RC-52 model but not in the FaDu model, in which Ga-68-FSC-(RGD)(3) showed significantly higher tumor uptake than Ga-68-TRAP-(RGD)(3). Most importantly, differences were also observed in normal tissues and in tumor-to-blood ratios. Conclusion: All tracers showed sufficient targeting of alpha(v)beta(3) integrin expression to allow for tumor detection. Although the highest tumor uptake was found for Ga-68-FSC-(RGD)(3) and Ga-68-THP-(RGD)(3) in the SK-RC-52 and FaDu models, respectively, selection of the optimal tracer for specific diagnostic applications also depends on tumor-to-blood ratio and uptake in normal tissues; these factors should therefore also be considered.
机译:α(v)β(3)整联蛋白在癌症中的血管生成和细胞迁移中起重要作用,并且在新形成的血管的活性内皮细胞上高度表达。在此,我们将4Ga-68标记的多聚体循环精氨酸 - 甘氨酸 - 天冬氨酸(RGD)的靶向特性进行比较α(v)β(3)表达蛋白的肿瘤模型和α( v)Beta(3)整合素仅在Neovascululation上表达。方法:用SK-RC-52(α(v)β(3)整联蛋白阳性)或FADU(α(v)β(3)整联蛋白阴性)肿瘤细胞皮下注射雌性BALB / C裸鼠。将68Ga标记的DOTA-(RGD)(2),捕获 - (RGD)(3),FSC-(RGD)(3),FSC-(RGD)(3)或THP-(RGD)(3)静脉内施用于小鼠(每小时0.5nmol ,10-20 MBQ),其次是小动物PET / CT成像和注射后1小时的exvivo生物分布研究。通过将过量的未标记的DOTA-(RGD)2(RGD)2(50nmol)与放射性标记的示踪剂一起突出,确定两种模型中的示踪剂的非特异性摄取。结果:成像和生物分布数据在两种型号中显示每个示踪剂的肿瘤中的特异性摄取。 Ga-68-FSC-(RGD)(3)的肿瘤摄取显着高于Ga-68-dota-(RGD)(2),Ga-68-Trap-(RGD)(3)或Ga- SK-RC-52模型中的68-THP-(RGD)(3),但不在FADU模型中,其中GA-68-FSC-(RGD)(3)显示出明显更高的肿瘤摄取而不是GA-68-TPAP - (RGD)(3)。最重要的是,在正常组织和肿瘤到血液比例中也观察到差异。结论:所有跟踪器显示α(v)β(3)整联蛋白表达的足够靶向,以允许肿瘤检测。虽然SK-RC-52和FADU模型中的GA-68-FSC-(RGD)(3)(3)和GA-68-THP-(RGD)(3)中发现了最高的肿瘤摄取分别选择了最佳选择特定诊断应用的示踪剂还取决于正常组织中的肿瘤到血液比率和摄取;因此也应考虑这些因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号